NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells
Hiroki J. Nakaoka(The University of Tokyo), Takeharu Sakamoto(The University of Tokyo)
Cited by 36
Related Papers
The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux
|Cell Discovery|2016|52
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus
|Scientific Reports|2016|18
Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock
|Communications Biology|2021|8
Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma
|Clinical and Translational Discovery|2023|4